Pharmaniaga's foray into Myanmar opens doors


KUALA LUMPUR: Pharmaniaga Bhd's successful foray into Myanmar with its Sinovac Covid-19 vaccine bodes well for its strategy to expand its vaccine distribution business beyond the local sector.

The pharmaceuticals group announced on Monday it had successfully exported the first batch of fill-finish Sinovac Covid-19 vaccines to Myanmar, manufactured by its wholly owned subsidiary Pharmaniaga Lifescience Sdn Bhd.

Celebrate Merdeka with 50% Off!
T&C applies.

Monthly Plan

RM13.90/month
RM6.95 only

Billed as RM6.95 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM6.17/month

Billed as RM78 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Pushing halal on global market
Audit all Malaysian carriers
SimeProp changes the game
Putting money on the banks
Conceive solutions to improve birth rates
Is TM better off exiting DNB?
A strategic shift for success
OSK in Johor asset buy
Economic proxy play
Mixed sentiment on EMS sector

Others Also Read